StockData
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.12+0.01 (+9.61%)

Close on Nov 18, 2026Market cap $6.20MP/E –Yield –

AEON Biopharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

AEON Biopharma's free cash flow for the twelve months ending Dec 31, 2025 was -$17.31M. For fiscal 2025 it was -$17.31M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.31M–
FY2022Dec 31, 2022-$35.89M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$4.71M–
Q3 FY2025Sep 30, 2025-$2.60M–
Q2 FY2025Jun 30, 2025-$2.09M–
Q1 FY2025Mar 31, 2025-$7.91M–
Q4 FY2022Dec 31, 2022-$8.46M–

More AEON Biopharma figures

See a number that looks wrong?